JAK2 and cyclic hematopoiesis: For instance, CH in patients undergoing aHSCT shares common mutational predominance involving DNMT3A and TET2 with other forms of CH but not ASXL1 or JAK2 [12, 35], which have been found in aging hematopoiesis.